Pronutria Biosciences pulls in $39 mln Series C
Cambridge, Massachusetts-based Pronutria Biosiences, a developer of treatments to mediate amino acid biology, has closed $39 million in Series C funding. Fidelity Management & Research Company led the round with participation from other investors that included Flagship Ventures.
28 May 2015•2 mins read
